“The powerful person would seem to have a good deal at stake in suppressing or denying his awareness of the personal reality of others; power seems to engender a kind of willed ignorance, a moral stupidity, about the inwardness of others, hence of oneself.”
-Adrienne Rich
"Failing to adopt [RCTs] that study the long-term effects of antidepressant withdrawal will continue to undercount prevalence, severity, and duration—the precise number of those affected longer-term and the length of time they can, and do, experience symptoms"
'Perhaps, despite our desire to be seen as individuals, we’re all just trying to belong somewhere.' 'A growing market is capitalising on the desirability of diagnosis as an indisputable medical claim to uniqueness.' https://t.co/2ZKB705m0H
CANMAT has rejected hyperbolic tapering as not being supported by RCTs and too difficult to implement. Yet they recommend linear tapering which has been found to cause severe withdrawal effects in most people in RCTs and unsuccessful in majority.
Si quieren saber más sobre “Maudsley Deprescribing Guidelines”, lineamientos internacionales para disminuir gradualmente los antidepresivos en pacientes, sigan a la Dra. Andrea Atri, Médica y psiquiatra por la UNAM, en Twitter como @andreaatri y en Instagram reduccion.gradual
Our survey of people in online support groups shows antidepressant withdrawal can be severe and protracted and that longer use predicts worse withdrawal effects @markhoro@ReadReadj https://t.co/vY8FZL46MV
Fue un placer regresar a mi facultad a presentar este proyecto que tanto me enorgullece.
(Thanks @markhoro)
Simposio - Maudsley Deprescribing Guidelines https://t.co/rQM9ADowB8 vía @YouTube
Publication of 'Deprescribing Guidelines' a turning point in history of psychiatry.
Many people are on meds they dont need or doses that are too high for durations that are too long
Docs are quick to prescribe/slow to deprescribe- & often don't know how.
Now there's no excuse:
#AlAire 🎙
Andrea Atri Mizrahi, médica psiquiatra y paciente con Esclerosis Múltiple habla de 'corriendo con Esclerosis Múltiple', #escúchala con @PamCerdeira 👩🏻🦱🎙
102.5 FM📻
https://t.co/4QSrM9hjgK
En 2023, la Organización Mundial de la Salud y las Naciones Unidas recalcaron la importancia del derecho de los pacientes a suspender el tratamiento y la necesidad de recibir apoyo para hacerlo.
El "Manual para Deprescribir de Maudsley" llena un vacío importante...
@ABCaustralia has reposted the @ConversationEDU piece on overprescribing of antidepressants "Overprescribing is also symptomatic of medicalisation of distress. Most diagnoses of depression and anxiety are descriptions masquerading as explanations" https://t.co/oKgxzye2o8
'A cultural change to reduce the reliance on medication and to support shared decision-making is needed, not least for mental health services.' https://t.co/czDLCYy11O
After 3 years of work with @DavidTa23968240 and many other psychiatrists, pharmacists and patient experts I am happy to see The Maudsley Deprescribing Guidelines get a publication date https://t.co/m2ltyNPLMQ (UK) https://t.co/TFl7NxWmrP (US)
"The 184-page document boldly spells out, in considerable detail, why new legislation is needed, around the world, to transcend the medical model espoused by drug companies, most psychiatrists, and even some psychologists." @ReadReadj
https://t.co/mLRSnvZTsw